Vaginal Atrophy: Symptoms and Treatment Options Compared

Why vaginal atrophy happens

Estrogen keeps the lining of the vagina thick, elastic and moist, supports a healthy acidic environment dominated by lactobacilli bacteria, and maintains blood flow. The urethra and bladder base have similar estrogen-sensitive tissue. When estrogen falls, the lining thins, produces less moisture, loses its folds and becomes fragile. The vaginal pH rises, making infections more likely.

Common causes of low estrogen:

• natural menopause and the years leading up to it
• surgical removal of the ovaries
• breast cancer treatment with aromatase inhibitors or tamoxifen-related changes, chemotherapy and pelvic radiation
• breastfeeding
• medicines that lower estrogen, such as some endometriosis and fertility drugs

The atrophic vaginitis page covers causes and diagnosis in more depth.

Symptoms

Vaginal and vulvar:

• vaginal dryness, burning or itching
• pain during sex and light bleeding after sex
• reduced arousal and lubrication
• a thin, watery or yellowish discharge
• a feeling of tightness or narrowing

Urinary:

• urgency and frequency
• burning when passing urine
• repeated urinary tract infections (recurrent UTI)
• leakage

Symptoms can start in perimenopause and usually get worse over time without treatment.

Treatment options compared

Vaginal moisturizers and lubricants

These are the first step for mild symptoms and the main option for people who cannot or do not want to use hormones. Moisturizers must be used regularly, not just before sex. Choose products without fragrance, glycerin-heavy formulas or warming agents if you are sensitive. A lubricant with a pH and concentration close to natural vaginal fluid is less irritating.

Low-dose vaginal estrogen

Vaginal estrogen is the most effective treatment for moderate to severe GSM. Symptoms often improve within 2 to 4 weeks, with full benefit after about 8 to 12 weeks. Treatment usually starts with nightly use for about 2 weeks, then continues twice weekly.

• Cream: flexible dosing and can be applied to the vulva, but can be messy.
• Tablet or soft insert: clean, pre-measured doses.
• Ring: placed in the vagina and replaced every 3 months, convenient for many people.

Blood estrogen levels stay in or near the postmenopausal range with low-dose products. The Menopause Society states that a progestogen is not needed to protect the womb lining with low-dose vaginal estrogen. In 2025 the FDA began removing the long-standing boxed warning from menopausal hormone therapy labels, including vaginal estrogen, and studies of vaginal estrogen have not shown increased risk of stroke, blood clots, breast cancer or womb cancer. Any vaginal bleeding during treatment should be reported.

Vaginal estrogen also lowers the risk of recurrent UTIs in postmenopausal women, and the American Urological Association recommends it for this purpose.

Treatments without strong evidence

Vaginal laser and radiofrequency treatments are marketed for "vaginal rejuvenation". The FDA has not approved them for GSM and has warned about burns, scarring and pain. Larger trials have not shown clear benefit over placebo, so they are not recommended outside research.

Vaginal atrophy after breast cancer

GSM is especially common and severe after breast cancer, particularly with aromatase inhibitors.

• Non-hormonal moisturizers and lubricants are the first choice.
• Pelvic floor physical therapy, dilators and topical lidocaine applied before sex can reduce pain.
• If symptoms persist, ACOG advises that low-dose vaginal estrogen may be considered after discussion with your oncologist. Many oncologists are comfortable with it for people on tamoxifen and are more cautious with aromatase inhibitors.
• Vaginal DHEA is sometimes considered, though data in survivors are limited.

Sex, comfort and pelvic floor care

• Regular sexual activity or vaginal stimulation increases blood flow and helps keep tissue elastic.
• Allow more time for arousal, and use plenty of lubricant.
• Vaginal dilators gently stretch tissue that has narrowed.
• Pelvic floor physical therapy helps when muscles tighten in response to pain (dyspareunia).
• Wear cotton underwear and avoid irritants such as scented products and douching.

Frequently asked questions

What is the best treatment for vaginal atrophy?

For mild symptoms, regular vaginal moisturizers plus a lubricant during sex often work well. For moderate to severe symptoms, low-dose vaginal estrogen is the most effective treatment. Vaginal DHEA and oral ospemifene are alternatives. The right choice depends on your symptoms, health history and preferences.

Is vaginal estrogen cream or tablet better?

Both work similarly well. Cream allows flexible dosing and can treat the vulva, but can be messy. Tablets and soft inserts are clean and pre-measured. A ring needs changing only every 3 months. Choose the form that fits your comfort and routine.

Is vaginal estrogen safe?

For most people, yes. Low-dose vaginal estrogen releases very little hormone into the blood, and studies have not shown increased risks of stroke, blood clots, breast cancer or womb cancer. Report any vaginal bleeding. People with a history of hormone-sensitive cancer should discuss it with their oncologist.

What is the difference between a vaginal moisturizer and a lubricant?

A moisturizer is used regularly, two to three times a week, to keep vaginal tissue hydrated day to day. A lubricant is used only during sex to reduce friction and discomfort. Many people with vaginal atrophy benefit from using both.

Does vaginal atrophy go away on its own?

No. Unlike hot flashes, which usually fade over time, vaginal atrophy tends to get worse without treatment because estrogen stays low after menopause. Symptoms return if treatment is stopped, so most people use moisturizers or vaginal estrogen long term.